Datavault AI (DVLT) Could Be 89% Undervalued Following Its Expanded DataMeds Deal

Datavault AI

Datavault AI

DVLT

0.00

Datavault AI (DVLT) is back on investor screens after amending its agreement with DataMeds AI to expand PharmacyChain licensing into broader healthcare and wellness, while restructuring its stake into common shares categorized as revenue.

Despite the expanded DataMeds AI agreement and recent management and investor events, Datavault AI’s short term momentum remains weak, with the share price down 24% in the last day and 72% year to date, alongside very heavy 3 and 5 year total shareholder return declines.

If this kind of volatility has you looking across the sector, it can help to compare Datavault AI with other data focused and chip adjacent plays using our screener of 30 AI small caps

After such steep share price losses and a complex DataMeds AI deal that is expected to feed into revenue, the question now is whether Datavault AI’s current valuation already reflects those risks or still leaves more downside than upside.

Most Popular Narrative: 89% Undervalued

Datavault AI’s most followed narrative sees fair value at $2.50 per share, far above the last close at $0.28, and builds a case around rapid growth in large, regulated data markets.

The announcement of multiple proprietary data exchange platforms (International Elements Exchange, NIL Exchange, Political Exchange) launching on compliant, AI-powered infrastructure positions Datavault AI to capitalize on accelerating digital transformation across sectors, suggesting significant future revenue growth as these exchanges monetize new verticals.

Want to see what sits behind that bold view on Datavault AI? The narrative leans heavily on fast expanding revenue, rising margins and a richer future earnings multiple. Curious which specific assumptions have to line up to support that $2.50 fair value?

Result: Fair Value of $2.50 (UNDERVALUED)

However, Datavault AI still faces concentration risks around key partnerships and complex revenue recognition that could quickly challenge the narrative that it is 89% undervalued.

Another View On Datavault AI’s Valuation

The analyst-led narrative paints Datavault AI as 89% undervalued at a fair value of $2.50 per share. The fair ratio approach tells a different story. Datavault AI trades on a P/S ratio of 5.8x against the estimated fair ratio of 128.3x and a peer average of 4.7x. That gap suggests either a very big upside case or a lot of valuation risk if expectations reset.

Before relying on any single ratio, it is worth seeing what the numbers indicate in more detail in our valuation breakdown. See what the numbers say about this price — find out in our valuation breakdown.

NasdaqCM:DVLT P/S Ratio as at Aug 2026
NasdaqCM:DVLT P/S Ratio as at Aug 2026

Next Steps

Given the mix of concern and optimism around Datavault AI, it makes sense to check the numbers yourself and weigh both sides quickly. To see how investors are currently balancing potential upside against the key issues they are watching, start with the 1 key reward and 3 important warning signs

Looking for more investment ideas beyond Datavault AI?

Do not stop with a single stock story. Use the Simply Wall St screener to spot fresh opportunities that fit your style before the crowd catches on.

  • Target potential mispricing by scanning for quality companies that may trade below their estimated value using the 51 high quality undervalued stocks.
  • Strengthen your income side by focusing on companies with higher yields and resilient payouts through the 8 dividend fortresses.
  • Reduce portfolio stress by concentrating on companies with sturdier finances and cleaner balance sheets using the solid balance sheet and fundamentals stocks screener (50 results).

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.